<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="inhibit novel coronavirus (SARS-CoV-2) in cell culture Emerging Microbes &amp;amp;" exact="Infections" post="Y.-N. Zhang et al. ZhangYa-Nanae*ZhangQiu-Yanbc*LiXiao-Danad*XiongJinaXiaoShu-QiaWangZhenfZhangZhe-RuiaeDengCheng-LinaYangXing-LouaWeiHong-Pingahttps://orcid.org/0000-0002-3234-9616YuanZhi-MingaYeHan-Qingahttps://orcid.org/0000-0002-8895-3679ZhangBoabcf[a], Key Laboratory of Special"/>
 <result pre="Biosafety Mega-Science, Chinese Academy of SciencesWuhanPeople’s Republic of China[b], The" exact="Joint" post="Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics,"/>
 <result pre="Guangzhou Women and Children’s Medical CenterGuangzhouPeople’s Republic of China[c], The" exact="Joint" post="Center of Translational Precision Medicine, Wuhan Institute of Virology,"/>
 <result pre="Academy of SciencesWuhanPeople’s Republic of China[d], School of Medicine, Hunan" exact="Normal" post="UniversityChangshaPeople’s Republic of China[e], University of Chinese Academy of"/>
 <result pre="Academy of SciencesBeijingPeople’s Republic of China[f], Drug Discovery Center for" exact="Infectious" post="Disease, Nankai UniversityTianjinPeople’s Republic of China CONTACT Han-Qing Ye"/>
 <result pre="work is properly cited. http://creativecommons.org/licenses/by/4.0/TEMI_9_1772676.pdf Abstract ABSTRACT The emerging SARS-CoV-2" exact="infection" post="associated with the outbreak of viral pneumonia in China"/>
 <result pre="ABSTRACT The emerging SARS-CoV-2 infection associated with the outbreak of" exact="viral pneumonia" post="in China is ongoing worldwide. There are no approved"/>
 <result pre="The emerging SARS-CoV-2 infection associated with the outbreak of viral" exact="pneumonia" post="in China is ongoing worldwide. There are no approved"/>
 <result pre="worldwide. There are no approved antiviral therapies to treat this" exact="viral" post="disease. Here we examined the antiviral abilities of three"/>
 <result pre="cell culture. We found that all three tested compounds inhibited" exact="viral" post="replication in Vero-E6 cells at noncytotoxic concentrations. The antiviral"/>
 <result pre="screening of antiviral compounds against newly emerging viruses to control" exact="viral infection." post="KEYWORDS Novel coronavirus alkaloid broad-spectrum antiviral 2019-nCoV SARS-CoV-2 fig-count:"/>
 <result pre="ref-count: page-count: Since the late 2019 when a cluster of" exact="pneumonia" post="associated with the emerging novel coronavirus, SARS-CoV-2 was reported"/>
 <result pre="to develop some antiviral compounds for the treatment of SARS-CoV-2" exact="infection" post="because of its high infectivity and morbidity and its"/>
 <result pre="tested antiviral activity of gemcitabine, lycorine and oxysophoridine against SARS-CoV-2" exact="infection" post="in cell culture, and chloroquine was used as a"/>
 <result pre="cells infected with SARS-CoV-2 (WIV04) [2] at a multiplicity of" exact="infection" post="(MOI) of 0.005 were treated with increased concentrations of"/>
 <result pre="of 0.005 were treated with increased concentrations of compounds. The" exact="viral" post="RNAs in cell culture media were quantified with quantitative"/>
 <result pre="0.18 and 1.36 μM, respectively. To confirm that the inhibition of" exact="viral" post="replication was not due to compound-mediated cytotoxicity, a cell"/>
 <result pre="30, respectively. We then performed indirect immunofluorescence assay (IFA) for" exact="viral" post="protein expression using anti-NP antibody to further verify the"/>
 <result pre="compounds for 24 hours. Real-time RT-PCR was used to quantify" exact="viral" post="RNA copy numbers in culture media. The cytotoxicity of"/>
 <result pre="blue, respectively. The EC50 and CC50 are displayed in the" exact="upper" post="right corner for each compound. At least three independent"/>
 <result pre="of compounds were fixed and subjected to IFA using the" exact="primary" post="antibody against NP protein of SARS-CoV-2. (C) Characterization of"/>
 <result pre="treated with increasing concentration of compounds for 72 hours, and" exact="viral" post="RNA copy numbers in culture media were quantified through"/>
 <result pre="antiviral agent against multiple RNA viruses which include Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV)"/>
 <result pre="agent against multiple RNA viruses which include Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV) [4],"/>
 <result pre="viruses which include Middle East respiratory syndrome coronavirus (MERS-CoV), severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) [4], Zika virus [5], influenza"/>
 <result pre="which include Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) [4], Zika virus [5], influenza virus"/>
 <result pre="include Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) [4], Zika virus [5], influenza virus [6]"/>
 <result pre="been demonstrated in the mice models of enterovirus and human" exact="immunodeficiency" post="virus (HIV) [7]. Additionally, the mean peak plasma concentration"/>
 <result pre="concentration of gemcitabine observed in patients with advanced non-small cell" exact="lung cancer" post="(NSCLC) could reach 17 µM after bronchial artery infusion or"/>
 <result pre="of gemcitabine observed in patients with advanced non-small cell lung" exact="cancer" post="(NSCLC) could reach 17 µM after bronchial artery infusion or"/>
 <result pre="vivo evaluation about the antiviral activity of gemcitabine against SARS-CoV-2" exact="infection" post="is going to be carried out in the near"/>
 <result pre="has various pharmacological activities, including suppression of the growth of" exact="hepatocellular carcinoma" post="[10] and colorectal cancer cells [11] by regulating apoptosis"/>
 <result pre="various pharmacological activities, including suppression of the growth of hepatocellular" exact="carcinoma" post="[10] and colorectal cancer cells [11] by regulating apoptosis"/>
 <result pre="including suppression of the growth of hepatocellular carcinoma [10] and" exact="colorectal cancer" post="cells [11] by regulating apoptosis associated with the Bcl-2/Bax/caspase-3"/>
 <result pre="suppression of the growth of hepatocellular carcinoma [10] and colorectal" exact="cancer" post="cells [11] by regulating apoptosis associated with the Bcl-2/Bax/caspase-3"/>
 <result pre="apoptosis associated with the Bcl-2/Bax/caspase-3 signalling pathway, and alleviation of" exact="spinal cord injury" post="via anti-inflammatory, anti-oxidative stress and anti-apoptosis effects [12]. In"/>
 <result pre="a new indication for oxysophoridine as a compound inhibiting SARS-CoV-2" exact="infection" post="in cell culture. To our knowledge, this is the"/>
 <result pre="in Amaryllidaceae with a wide range of biological functions for" exact="cancer" post="and infectious diseases treatment [13]. Unlike oxysophoridine, lycorine has"/>
 <result pre="with a wide range of biological functions for cancer and" exact="infectious diseases" post="treatment [13]. Unlike oxysophoridine, lycorine has been well known"/>
 <result pre="to exhibit antiviral activities against enterovirus, flaviviruses, HIV-1, SARS-CoV and" exact="hepatitis C" post="virus. Regarding the exact antiviral mechanism of lycorine, however,"/>
 <result pre="drug resistant mutations of lycorine have been identified within the" exact="viral" post="protease of enterovirus or nonstructural protein 2 K of West"/>
 <result pre="and (ii) downregulate autophagy [15] or block the elongation of" exact="viral" post="RNA translation during EV71 infection [13] to suppress viral"/>
 <result pre="or block the elongation of viral RNA translation during EV71" exact="infection" post="[13] to suppress viral replication. Altogether, we speculate that"/>
 <result pre="of viral RNA translation during EV71 infection [13] to suppress" exact="viral" post="replication. Altogether, we speculate that the mechanism behind the"/>
 <result pre="probably attributed to modulating host factors instead of directly targeting" exact="viral" post="factors. Overall, more information is needed regarding anti-SARS-CoV-2 issues"/>
 <result pre="ZhengXS, ZhaoK, ChenQJ, DengF, LiuLL, YanB, ZhanFX, WangYY, XiaoGF, ShiZL.2020A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="FriemanMB.2014Repurposing of clinically developed drugs for treatment of Middle East" exact="respiratory" post="syndrome coronavirus infection. Antimicrob Agents Chemother58:4885-93. doi: 10.1128/AAC.03036-1424841273 5KuivanenS,"/>
 <result pre="of clinically developed drugs for treatment of Middle East respiratory" exact="syndrome" post="coronavirus infection. Antimicrob Agents Chemother58:4885-93. doi: 10.1128/AAC.03036-1424841273 5KuivanenS, BespalovMM,"/>
 <result pre="5KuivanenS, BespalovMM, NandaniaJ, et al.Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika" exact="virus infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
 <result pre="BespalovMM, NandaniaJ, et al.Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus" exact="infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
 <result pre="KakkolaL, FengL, et al.Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a" exact="virus infection." post="J Biol Chem. 2012;287:35324–32. doi: 10.1074/jbc.M112.39214222910914 7LeeK, KimDE, JangKS,"/>
 <result pre="KimDE, JangKS, et al.Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus" exact="infections" post="through innate immunity induced by the inhibition of pyrimidine"/>
 <result pre="8AlharbiAF, KratzkeRA, D’CunhaJ, et al.Gemcitabine and metabolite pharmacokinetics in advanced" exact="NSCLC" post="patients after bronchial artery infusion and intravenous infusion. Cancer"/>
 <result pre="advanced NSCLC patients after bronchial artery infusion and intravenous infusion." exact="Cancer" post="Chemother Pharmacol. 2019;83:387–391. doi: 10.1007/s00280-018-3757-730542769 9QiFH, WangZX, CaiPP, et"/>
 <result pre="and related active compounds: a review of their role on" exact="hepatitis" post="B virus infection. Drug Discov Ther. 2013;7:212–24. doi: 10.5582/ddt.2013.v7.6.21224423652"/>
 <result pre="active compounds: a review of their role on hepatitis B" exact="virus infection." post="Drug Discov Ther. 2013;7:212–24. doi: 10.5582/ddt.2013.v7.6.21224423652 10YaoXQ, ZhangYH, LongW,"/>
 <result pre="10.5582/ddt.2013.v7.6.21224423652 10YaoXQ, ZhangYH, LongW, et al.Oxysophoridine suppresses the growth of" exact="hepatocellular carcinoma" post="in mice: in vivo and cDNA microarray studies. Chin"/>
 <result pre="10YaoXQ, ZhangYH, LongW, et al.Oxysophoridine suppresses the growth of hepatocellular" exact="carcinoma" post="in mice: in vivo and cDNA microarray studies. Chin"/>
 <result pre="in vitro induction of the apoptotic effects of oxysophoridine on" exact="colorectal cancer" post="cells via the Bcl-2/Bax/caspase-3 signaling pathway. Oncol Lett. 2017;14:8000–8006.29344242"/>
 <result pre="vitro induction of the apoptotic effects of oxysophoridine on colorectal" exact="cancer" post="cells via the Bcl-2/Bax/caspase-3 signaling pathway. Oncol Lett. 2017;14:8000–8006.29344242"/>
 <result pre="pathway. Oncol Lett. 2017;14:8000–8006.29344242 12CaoZ, ChenL, LiuY, et al.Oxysophoridine rescues" exact="spinal cord injury" post="via antiinflammatory, antioxidative stress and antiapoptosis effects. Mol Med"/>
 <result pre="inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic" exact="avian influenza" post="virus H5N1. Infl Other Respir Viruses. 2013;7:922–31. doi: 10.1111/irv.12035"/>
</results>
